Advertisement
Screener

Onconetix, Inc. (ONCO) Finite-Lived Intangible Asset, Expected Amortization, Year One

2.8 / 5 stars · 68/120 Roast Me

Onconetix, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year One

Onconetix, Inc. (ONCO) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $852.96 thousand as of 2024-09-30, per its 10-Q filed 2024-12-10.

Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2024-12-10

  • 2024-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $852.96K.
  • 2024-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $801.18K.
  • 2024-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $968.46K.
  • 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.01M.
Period endFinite-Lived Intangible Asset, Expected Amortization, Year One
2024-09-30$852.96K
10-Q · filed 2024-12-10
2024-06-30$801.18K
10-Q · filed 2024-08-29
2024-03-31$968.46K
10-Q · filed 2024-05-20
2023-12-31$1.01M
10-K · filed 2024-04-11
2023-06-30$4.00M
10-Q · filed 2023-10-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
HCW Biologics Inc. (HCWB)United States$0.004B-6.15
REVELATION BIOSCIENCES, INC. (REVB)United States$0.004B
Aptevo Therapeutics Inc. (APVO)United States$0.003B
Sunshine Biopharma Inc. (SBFM)$0.003B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59
Alaunos Therapeutics, Inc. (TCRT)United States$0.003B-1.44
Genprex, Inc. (GNPX)United States$0.003B-0.02
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90